HOME › DRUGS › DACLATASVIR DIHYDROCHLORIDE
ACTIVE SUBSTANCE / INN

DACLATASVIR DIHYDROCHLORIDE

Brand name(s): DAKLINZA
FDA LISTED
DISCONTINUED
NDA206843
ACTIVE SUBSTANCE
Daclatasvir Dihydrochloride
REGULATORS
FDA
SPONSORS / MAH
BRISTOL-MYERS SQUIBB
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DAKLINZANDA206843BRISTOL-MYERS SQUIBBDiscontinued

FULL INTELLIGENCE ON DACLATASVIR DIHYDROCHLORIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →